Jeremy Bier, DPM
Podiatrist · Stamford, CTNPI 1205859865
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (47.3%), education and travel and lodging — rather than concentrated in one kind of arrangement. 30 manufacturers reported payments, led by Gotham Surgical Solutions & Devices, Inc. at 35.4% of the total. Reporting peaked in 2019 at $2,539 and has fallen 78.0% since, to $559 in 2025. Among podiatrist clinicians in CT with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 95 payments — averaging $61.51 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Gotham Surgical Solutions & Devices, Inc.$2K
- Treace Medical Concepts, Inc.$2K
- Smith+Nephew$397
- Stryker$320
- Paratek Pharmaceuticals, Inc.$289
- Medtronic$167
- plus $1K from 24 others
What the payments were for
- Travel & lodging$1,01017%
- Food & beverage$2,76647%
- Education$2,06835%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Gotham Surgical Solutions & Devices, Inc. | 1 | $2,068 |
| Treace Medical Concepts, Inc. | 8 | $1,506 |
| Smith+Nephew | 22 | $397 |
| Stryker | 6 | $320 |
| Paratek Pharmaceuticals, Inc. | 16 | $289 |
| Medtronic | 4 | $167 |
| Bioventus LLC | 5 | $143 |
| Osiris Therapeutics Inc. | 1 | $120 |
| Kerecis Limited | 2 | $78 |
| Averitas Pharma Inc. | 3 | $76 |
| Organogenesis Inc. | 4 | $75 |
| Biotissue Holdings Inc. | 3 | $72 |
| Celularity Inc. | 1 | $64 |
| Novastep Inc. | 1 | $50 |
| Polynovo North America LLC | 2 | $44 |
| Zimvie Inc. | 1 | $41 |
| Vertex | 1 | $35 |
| Hikma Pharmaceuticals USA | 2 | $34 |
| Acera Surgical, Inc. | 1 | $33 |
| Nevro Corp. | 1 | $30 |
| Polaris Technology Solutions LLC | 1 | $27 |
| Reapplix Inc. | 1 | $23 |
| ANI Pharmaceuticals, Inc. | 1 | $22 |
| Amgen | 1 | $21 |
| Sandoz | 1 | $20 |
| Lifenet Health | 1 | $20 |
| Reprise Biomedical, Inc. | 1 | $20 |
| Sebela Pharmaceuticals Inc. | 1 | $17 |
| Integra Lifesciences Corporation | 1 | $17 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$5,843 in reported general payments places this provider in the 90th percentile of 119 podiatrist providers in Connecticut.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| SantylCollagenase Clostridium Hist. | 20 | $6,565 |
| Colchicine | 26 | $3,743 |
| Lidocaine | 14 | $1,456 |
| Ketoconazole | 52 | $1,392 |
| Gabapentin | 106 | $888 |
| Ciclopirox | 26 | $823 |
| Ammonium Lactate | 57 | $673 |
| CiclopiroxCiclopirox Olamine | 23 | $566 |
| Allopurinol | 51 | $507 |
| Fluconazole | 51 | $430 |
| Pregabalin | 30 | $385 |
| Celecoxib | 21 | $385 |
| Terbinafine Hcl | 31 | $350 |
| Meloxicam | 112 | $320 |
| Ciprofloxacin Hcl | 26 | $295 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Smith+NephewSantyl | $397 | $6,56520 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 119 podiatrist providers in Connecticut.
Other podiatrist in Stamford
- Sanford PronerStamford$1K
- Susan GlasmanStamford$549
- Peter BlumeNew Haven$481K
- Robert DavisBridgeport$427K
- David NovickiMilford$67K
- Shane ReynoldsNorwalk$14K
- Eric LevineNorwich$12K
- Paul BetschartDanbury$10K
- Michael FeinBethel$9K
- Tehreem SajjadNew Britain$9K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.